NCT07860801 · Memorial Sloan Kettering Cancer Center
Study of Vaping Use Among Adolescent and Young Adult Patients With Cancer
What this study is about
The purpose of this study is to learn more about how adolescent and young adult (AYA) cancer patients, their parents and caregivers (referred to as a carebuddy in this study), and their healthcare providers think about and communicate around vaping and tobacco use.
View original scientific description
The purpose of this study is to learn more about how adolescent and young adult (AYA) cancer patients, their parents and caregivers (referred to as a carebuddy in this study), and their healthcare providers think about and communicate around vaping and tobacco use. We hope this information will help us develop educational materials and provider training tools that are appropriate for young people with cancer. A Community Advisory Board that is made up of AYA patients, parents/caregivers, and healthcare providers, is helping to guide the study. The board will review the materials, give feedback, help the study team understand the findings, and provides input to make sure the study is appropriate and practical for participants.
Interventions
OTHER
Study assessments
Patient and Parent/Carebuddy Survey, Provider Survey, AYA Patient Focus Group Guide, Parent/Caregiver Focus Group Guide
Primary outcome measures
support needs to inform the development of developmentally appropriate vaping cessation resources.
Time frame: 1 year
using study assessments
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- History of cancer diagnosis;
- Report vaping within the past 12 months as documented in the medical record, clinician note, and/or self-report;
- Age 15-39 years at date of consent;
- Receiving or have received treatment at MSK;
- Iidentify English as primary language as per medical record
- Self-report they are the parent/carebuddy of an AYA patient who currently or previously vaped.
- Conducts ≥2 AYA clinical consultations weekly as per self-report or EMR;
- Is an MSK clinician (i.e., nurse practitioner, social worker, physician assistant, physician)
Exclusion criteria
- Acute psychiatric symptoms impairing participation as per the EMR or as per clinician judgment;
- Reports exclusive use of combustible or smokeless tobacco products (i.e., no history of nicotine vaping).
Where
- Basking Ridge, New Jersey
- Middletown, New Jersey
- Montvale, New Jersey
- Commack, New York
- Harrison, New York
- New York, New York
- Uniondale, New York
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Oct 6, 2026 · Source of record for eligibility and locations